Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol
Open Access
- 19 January 2021
- journal article
- research article
- Published by Elsevier BV in Contemporary Clinical Trials Communications
- Vol. 21, 100716
- https://doi.org/10.1016/j.conctc.2021.100716
Abstract
No abstract availableKeywords
Funding Information
- Generalitat de Catalunya
This publication has 29 references indexed in Scilit:
- Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysisCritical Care Medicine, 2020
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Corticosteroids as adjunctive therapy in the treatment of influenzaCochrane Database of Systematic Reviews, 2016
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation SyndromeCritical Care Medicine, 2016
- Simultaneous Measurement of Cyclosporine A, Everolimus, Sirolimus and Tacrolimus Concentrations in Human Blood by UPLC–MS/MSChromatographia, 2015
- Adult haemophagocytic syndromeThe Lancet, 2014
- Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506Virus Research, 2012
- Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cellsLiver Transplantation, 2008
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004